U.K, Jan. 12 -- Roche has launched two AI-powered image analysis systems to help with breast cancer detection.
The two new automated algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis, will help pathologists decide on the best treatment strategy for each patient.
The uPath HER2 (4B5) image analysis helps pathologists quickly detect whether tumors are positive for the HER2 biomarker, highlighting positively stained tumor cell membranes with a clear visual overlay for easy reference.
The second algorithm, uPath HER2 Dual ISH, assists the pathologist in the determination of HER2 gene amplification. A heatmap guides the clinicians to areas of interest where the algorithm can identify cells that need targeting. ...